Spain Antifungal Drugs Market Size & Outlook, 2026-2033

The antifungal drugs market in Spain is expected to reach a projected revenue of US$ 329.6 million by 2033. A compound annual growth rate of 2.9% is expected of Spain antifungal drugs market from 2026 to 2033.
Revenue, 2025 (US$M)
$262.9
Forecast, 2033 (US$M)
$329.6
CAGR, 2026 - 2033
2.9%
Report Coverage
Spain

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Spain antifungal drugs market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Spain antifungal drugs market highlights

  • The Spain antifungal drugs market generated a revenue of USD 262.9 million in 2025 and is expected to reach USD 329.6 million by 2033.
  • The Spain market is expected to grow at a CAGR of 2.9% from 2026 to 2033.
  • In terms of segment, azoles was the largest revenue generating drug class in 2025.
  • Echinocandins is the most lucrative drug class segment registering the fastest growth during the forecast period.


Antifungal drugs market data book summary

Market revenue in 2025USD 262.9 million
Market revenue in 2033USD 329.6 million
Growth rate2.9% (CAGR from 2026 to 2033)
Largest segmentAzoles
Fastest growing segmentEchinocandins
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAzoles, Echinocandins, Polyenes, Allylamines
Key market players worldwideNovartis AG ADR, Pfizer Inc, Bayer AG, Sanofi SA, Merck KGaA, Merck & Co Inc, GlaxoSmithKline, Abbott Laboratories, Enzon Pharmaceuticals Inc, Astellas Pharma Inc, Glenmark Pharmaceuticals


Other key industry trends

  • In terms of revenue, Spain accounted for 1.6% of the global antifungal drugs market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, Germany antifungal drugs market is projected to lead the regional market in terms of revenue in 2033.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 1,405.2 million by 2033.

Azoles was the largest segment with a revenue share of 49.41% in 2025. Horizon Databook has segmented the Spain antifungal drugs market based on azoles, echinocandins, polyenes, allylamines covering the revenue growth of each sub-segment from 2021 to 2033.


The Spanish Agency for Medicines and Health Products (AEMPS) is the national healthcare authority responsible for the regulation of medicines in Spain. It was established in 1999 as the health authority of reference for healthcare professionals and citizens in the field of quality assurance, efficiency, safety, and information & accessibility to drugs. 

The generic drugs are regulated as per the law 29/2006 passed on July 2006, which protects the coherent use of medical devices and medicines, and Royal Decree 1345/2007 of October 2007, which regulates the authorization, registration, and supply of medicinal products for treating patients. 

The average time for generic drug approval is more than 14 months, which is second to Greece in the EU. Thus, delays in the approval of new medicine are anticipated to restrain the market. The marketing authorization is granted based on scientific criteria of quality, safety, and efficacy of the medicinal product.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Antifungal Drugs Market Companies

Name Profile # Employees HQ Website
Glenmark Pharmaceuticals View profile 10001+ Andheri, Maharashtra, India, Asia http://www.glenmarkpharma.com
GlaxoSmithKline View profile 10001+ London, England, United Kingdom, Europe http://www.gsk.com
Astellas Pharma Inc View profile 14484 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 http://www.astellas.com
Enzon Pharmaceuticals Inc View profile 1 20 Commerce Drive, Suite 135, Cranford, NJ, United States, 07016 http://www.enzon.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

Spain antifungal drugs market size, by drug class, 2021-2033 (US$M)

Spain Antifungal Drugs Market Outlook Share, 2025 & 2033 (US$M)

Spain antifungal drugs market size, by drug class, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online